Role of granulocytes and monocytes in the polyvinyl chloride-induced synthesis of interleukin 8, monocyte chemoattractant protein 1, and leukotriene B4

Journal of Biomedical Materials Research - Part A

Volumn 74, Issue 2, 2005, Pages 230-236

  Lappegård, Knut Tore ^a,b   Bergseth, Grethe ^a,b   Riesenfeld, Johan ^c   Sexton, Joe ^d   Mollnes, Tom Eirik ^a,b,e  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Carmeda AB   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Biocompatibility; Granulocytes; Inflammation; Leukocytes; Monocytes; Polyvinyl chloride

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BLOOD; CELLS; CONCENTRATION (PROCESS); MONOCLONAL ANTIBODIES; POLYVINYL CHLORIDES; SYNTHESIS (CHEMICAL);

GRANULOCYTES; INFLAMMATORY MEDIATORS; LEUKOCYTE SURFACE ANTIGENS; MAGNETIC BEADS;

PROTEINS;

INTERLEUKIN 8; LEUKOTRIENE B4; MEMBRANE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYVINYLCHLORIDE;

ANTIBODY DETECTION; ARTICLE; CELL SPECIFICITY; CELL TYPE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MATERIALS TESTING; MONOCYTE; PROSTHESIS MATERIAL;

CHEMOKINE CCL2; COMPLEMENT ACTIVATION; GRANULOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-8; LEUKOTRIENE B4; MONOCYTES; POLYVINYL CHLORIDE;

EID: 22244479716     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30372     Document Type: Article

References (28)

1. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-S720.
2. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66:S12-S16.
3. Lappegård KT, Fung M, Bergseth G, Riesenfeld J, Lambris JD, Videm V, Mollnes TE. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg 2004;77:932-941.
4. Lappegård KT, Fung M, Bergseth G, Riesenfeld J, Mollnes TE. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition. Ann Thorac Surg 2004;78: 38-44.
5. Lappegård KT, Riesenfeld J, Brekke OL, Bergseth G, Lambris JD, Mollnes TE. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. Ann Thorac Surg 2005;79:917-923.
6. Ryu JS, Kang JH, Jung SY, Shin MH, Kim JM, Park H, Min DY. Production of interleukin-8 by human neutrophils stimulated with trichomonas vaginalis. Infect Immun 2004;72:1326-1332.
7. Rose F, Hattar K, Gakisch S, Grimminger F, Olschewski H, Seeger W, Tschuscnner A, Schermuly RT, Weissmann N, Hanze J, Sibelius U, Ghofrani HA. Increased neutrophil mediator release in patients with pulmonary hypertension: suppression by inhaled iloprost. Thromb Haemost 2003;90:1141-1149.
8. Cudd L, Clarke C, Clinkenbeard K. Mannheimia haemolytica leukotoxin-induced increase in leukotriene B4 production by bovine neutrophils is mediated by a sustained and excessive increase in intracellular calcium concentration. FEMS Microbiol Lett 2003;224:85-90.
9. Yamamoto K, Ikeda U, Shimada K. Role of mechanical stress in monocytes/macrophages: implications for atherosclerosis. Curr Vasc Pharmacol 2003;1:315-319.
10. Baksaas ST, Videm V, Pedersen T, Karlsen H, Mollnes TE, Brosstad F, Svennevig JL. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices. Perfusion 1999;14:119-127.
11. Videm V, Mollnes TE, Garred P, Svennevig JL. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1991;101:654-660.
12. Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992;103:806-813.
13. Øvrum E, Mollnes TE, Fosse E, Holen EA, Tangen G, Ringdal MA, Videm V. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. Ann Thorac Surg 1995;60:1755-1761.
14. Mollnes TE, Riesenfeld J, Garred P, Nordstrom E, Hogasen K, Fosse E, Gotze O, Harboe M. A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Artif Organs 1995;19:909-917.
15. Mollnes TE, Brekke OL, Fung M, Pure H, Christiansen D, Bergseth G, Videm V, Lappegard KT, Kohl J, Lambris JD. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002;100;1869-1877.
16. Takeshita S, Nakatani K, Takata Y, Kawase H, Sekine I, Yoshioka S. Interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) enhance lipopolysaccharide binding to neutrophils via CD14. Inflamm Res 1998;47:101-103.
17. Weingarten R, Sklar LA, Mathison JC, Omidi S, Ainsworth T, Simon S, Ulevitch RJ, Tobias PS. Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukoc Biol 1993;53:518-524.
18. Sbrana S, Parri MS, De Filippis R, Gianetti J, Clerico A. Monitoring of monocyte functional state after extracorporeal circulation: a flow cytometry study. Cytometry 2004;58B:17-24.
19. Osterud B. The role of platelets in decrypting monocyte tissue factor. Dis Mon 2003;49:7-13.
20. Mollnes TE, Lea T, Froland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985;22:197-202.
21. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, Kobayashi M. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia 1997;40:610-613.
22. Okada M, Matsumori A, Ono K, Furukawa Y, Shioi T, Iwasaki A, Matsushima K, Sasayama S. Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:894-901.
23. Hasper D, Hummel M, Hetzer R, Volk HD. Blood contact with artificial surfaces during BVAD support. Int J Artif Organs 1996;19:590-596.
24. Bustos C, Hernandez-Presa MA, Ortego M, Tunon J, Ortega L, Perez F, Diaz C, Hernandez G, Egido J. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998;32: 2057-2064.
25. de Haij S, Woltman AM, Bakker AC, Daha MR, van Kooten C. Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids. Br J Pharmacol 2002;137:197-204.
26. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001;175:81-92.
27. Romano M, Diomede L, Sironi M, Massimiliano L, Sottocorno M, Polentarutti N, Guglielmotti A, Albani D, Bruno A, Fruscella P, Salmona M, Vecchi A, Pinza M, Mantovani A. Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest 2000;80:1095-1100.
28. Marleau S, Fruteau de Laclos B, Sanchez AB, Poubelle PE, Borgeat P. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit. J Immunol 1999;163:3449-3458.